DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Goette A, Merino JL, Ezekowitz MD. et al; ENSURE-AF Investigators.
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Lancet 2016;
388 (10055): 1995-2003
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.